Plummer-Vinson syndrome

Orphanet J Rare Dis. 2006 Sep 15:1:36. doi: 10.1186/1750-1172-1-36.

Abstract

Plummer-Vinson or Paterson-Kelly syndrome presents as a classical triad of dysphagia, iron-deficiency anemia and esophageal webs. Exact data about epidemiology of the syndrome are not available; the syndrome is extremely rare. Most of the patients are white middle-aged women, in the fourth to seventh decade of life but the syndrome has also been described in children and adolescents. The dysphagia is usually painless and intermittent or progressive over years, limited to solids and sometimes associated with weight loss. Symptoms resulting from anemia (weakness, pallor, fatigue, tachycardia) may dominate the clinical picture. Additional features are glossitis, angular cheilitis and koilonychia. Enlargement of the spleen and thyroid may also be observed. One of the most important clinical aspects of Plummer-Vinson syndrome is the association with upper alimentary tract cancers. Etiopathogenesis of Plummer-Vinson syndrome is unknown. The most important possible etiological factor is iron deficiency. Other possible factors include malnutrition, genetic predisposition or autoimmune processes. Plummer-Vinson syndrome can be treated effectively with iron supplementation and mechanical dilation. In case of significant obstruction of the esophageal lumen by esophageal web and persistent dysphagia despite iron supplementation, rupture and dilation of the web are necessary. Since Plummer-Vinson syndrome is associated with an increased risk of squamous cell carcinoma of the pharynx and the esophagus, the patients should be followed closely.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Aged
  • Aged, 80 and over
  • Deglutition Disorders / diagnosis
  • Diagnosis, Differential
  • Female
  • Global Health
  • Humans
  • Iron / therapeutic use
  • Male
  • Middle Aged
  • Plummer-Vinson Syndrome / diagnosis*
  • Plummer-Vinson Syndrome / epidemiology
  • Plummer-Vinson Syndrome / therapy*
  • Prevalence
  • Prognosis
  • Rare Diseases
  • Sex Distribution
  • Young Adult

Substances

  • Iron